Preclinical Development of a Cord Blood (CB)-Derived Hematopoietic Stem Cell (HSC) Product for Allogeneic Transplantation in Patients with Hematological Malignancies

Iancu-Rubin Camelia; Fong Helen; Mosoyan Goar; Patel Ami; Sabado Rachel; Marcia Meseck; Moshier Erin; Ozbek Umut; Keyzner Alla; Bhardwaj Nina; McNiece Ian K.; Tong Jay; Hoffman Ronald

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Preclinical Development of a Cord Blood (CB)-Derived Hematopoietic Stem Cell (HSC) Product for Allogeneic Transplantation in Patients with Hematological Malignancies

【24h】

Preclinical Development of a Cord Blood (CB)-Derived Hematopoietic Stem Cell (HSC) Product for Allogeneic Transplantation in Patients with Hematological Malignancies

机译：脐血（CB）衍生的造血干细胞（HSC）产品用于血液系统恶性肿瘤同种异体移植的临床前开发

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2016年第22期|共6页
作者
Iancu-Rubin Camelia; Fong Helen; Mosoyan Goar; Patel Ami; Sabado Rachel; Marcia Meseck; Moshier Erin; Ozbek Umut; Keyzner Alla; Bhardwaj Nina; McNiece Ian K.; Tong Jay; Hoffman Ronald;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Preclinical Development of a Cord Blood (CB)-Derived Hematopoietic Stem Cell (HSC) Product for Allogeneic Transplantation in Patients with Hematological Malignancies [J] . Iancu-Rubin Camelia, Fong Helen, Mosoyan Goar, Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：脐血（CB）衍生的造血干细胞（HSC）产品用于血液系统恶性肿瘤同种异体移植的临床前开发
2. Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies. [J] . Pavletic ZS, Bishop MR, Tarantolo SR, Journal of Clinical Oncology . 1997,第4期

机译：血液系统恶性肿瘤患者同种异体血液干细胞移植后的造血恢复与骨髓移植相比。
3. Impact of Daptomycin Minimum Inhibitory Concentration (MIC) on Outcomes of Patients with Hematologic Malignancies and Hematopoietic Stem Cell Transplant (HSCT) Recipients with Vancomycin-Resistant Enterococci (VRE) Bloodstream Infection (BSI) [J] . Chong Pearlie P., van Duin David, Bangdiwala Ananta, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第2Suppla1期

机译：达托霉素最低抑菌浓度（MIC）对耐万古霉素肠球菌（VRE）血液感染（BSI）的血液系统恶性肿瘤和造血干细胞移植（HSCT）患者的结局的影响
4. Intravenous Busulfan Reduces Toxicity Associated with Myeloablative Allogeneic Hematopoietic Transplantation in Patients with Myeloid Malignancies [C] . A. Shimoni, B. Bxelorai, I. Hardan, European Haematology Association . 2002

机译：静脉内的伯鲁兰减少骨髓恶性肿瘤患者患有髓鞘异产造血移植的毒性
5. The burden of parainfluenza virus infection in patients with hematological malignancy and hematopoietic stem cell transplant (HSCT) recipients in the absence of active immunization and approved therapy: The role of infection control. [D] . Hanmod, Santosh S. 2009

机译：在没有积极免疫和批准治疗的情况下，血液恶性肿瘤和造血干细胞移植（HSCT）患者的副流感病毒感染负担：感染控制的作用。
6. Transplantation: Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood [O] . Claudio G. Brunstein, Jonathan A. Gutman, Daniel J. Weisdorf, -1

机译：移植：异基因造血细胞移植治疗血液系统恶性肿瘤：双脐带血的相对风险和收益
7. Hematopoietic stem cell transplantation (HSCT) for malignancies using umbilical cord blood units (UCB) that were not red blood cell depleted [O] . Chow R., Nademanee A., Rosenthal J., 2006

机译：使用未耗尽红细胞的脐带血单位（UCB）进行造血干细胞移植（HSCT）进行恶性肿瘤

Preclinical Development of a Cord Blood (CB)-Derived Hematopoietic Stem Cell (HSC) Product for Allogeneic Transplantation in Patients with Hematological Malignancies

著录项

相似文献

相关主题

期刊订阅